These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19474114)

  • 1. Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
    Okines AFC; Norman AR; McCloud P; Kang YK; Cunningham D
    Ann Oncol; 2009 Sep; 20(9):1529-1534. PubMed ID: 19474114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capecitabine for the treatment of advanced gastric cancer.
    Norman G; Soares M; Peura P; Rice S; Suh D; Wright K; Sculpher M; Eastwood A
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):11-7. PubMed ID: 21047486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.
    Chau I; Norman AR; Cunningham D; Oates J; Hawkins R; Iveson T; Nicolson M; Harper P; Seymour M; Hickish T
    Ann Oncol; 2009 May; 20(5):885-91. PubMed ID: 19164454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.
    Evans TR; Pentheroudakis G; Paul J; McInnes A; Blackie R; Raby N; Morrison R; Fullarton GM; Soukop M; McDonald AC
    Ann Oncol; 2002 Sep; 13(9):1469-78. PubMed ID: 12196374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients.
    Cassidy J; Saltz L; Twelves C; Van Cutsem E; Hoff P; Kang Y; Saini JP; Gilberg F; Cunningham D
    Ann Oncol; 2011 Dec; 22(12):2604-2609. PubMed ID: 21415237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.
    Ter Veer E; Ngai LL; Valkenhoef GV; Mohammad NH; Anderegg MCJ; van Oijen MGH; van Laarhoven HWM
    Sci Rep; 2017 Aug; 7(1):7142. PubMed ID: 28769123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial.
    Grenader T; Waddell T; Peckitt C; Oates J; Starling N; Cunningham D; Bridgewater J
    Ann Oncol; 2016 Apr; 27(4):687-92. PubMed ID: 26787231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer.
    Wu FL; Lu DC; Ying YP; Huang JJ; Zhou AM; Jiang DK; Chen MW; Yang X; Zhou J; Huang HQ; Zeng HY
    Medicine (Baltimore); 2015 Apr; 94(16):e652. PubMed ID: 25906091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine: in advanced gastric or oesophagogastric cancer.
    Dhillon S; Scott LJ
    Drugs; 2007; 67(4):601-10. PubMed ID: 17352519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer.
    Ryu MH; Kang YK
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1745-51. PubMed ID: 19954285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2-negative advanced gastric cancer.
    Bilici A; Selcukbiricik F; Demir N; Oven Ustaalioglu BB; Dikilitas M; Yildiz O
    Asian Pac J Cancer Prev; 2014; 15(20):8661-6. PubMed ID: 25374186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between expression of thymidylate synthase and clinical outcome of advanced gastric cancer treated with capecitabine alone chemotherapy.
    Liu XF; Zhang H; Sun JQ; Yin C; Liu TF; Yang H; Chen LH
    Tumour Biol; 2014 Dec; 35(12):12409-14. PubMed ID: 25185651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in human epidermal growth factor receptor 2-positive advanced oesophagogastric cancer: A meta-analysis.
    Ter Veer E; Creemers A; de Waal L; van Oijen MGH; van Laarhoven HWM
    Int J Cancer; 2018 Jul; 143(2):438-448. PubMed ID: 29451302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
    Starling N; Rao S; Cunningham D; Iveson T; Nicolson M; Coxon F; Middleton G; Daniel F; Oates J; Norman AR
    J Clin Oncol; 2009 Aug; 27(23):3786-93. PubMed ID: 19398575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis.
    Zhu L; Liu J; Ma S
    Pathol Oncol Res; 2016 Oct; 22(4):853-61. PubMed ID: 27236591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
    He MM; Wu WJ; Wang F; Wang ZQ; Zhang DS; Luo HY; Qiu MZ; Wang FH; Ren C; Zeng ZL; Xu RH
    PLoS One; 2013; 8(12):e82798. PubMed ID: 24349363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.
    Gilabert M; Bertucci F; Esterni B; Madroszyk A; Tarpin C; Jacquemier J; Extra JM; Viens P; Gonçalves A
    Anticancer Res; 2011 Mar; 31(3):1079-86. PubMed ID: 21498742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
    Lordick F; Kang YK; Chung HC; Salman P; Oh SC; Bodoky G; Kurteva G; Volovat C; Moiseyenko VM; Gorbunova V; Park JO; Sawaki A; Celik I; Götte H; Melezínková H; Moehler M;
    Lancet Oncol; 2013 May; 14(6):490-9. PubMed ID: 23594786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine.
    Yu J; Gao J; Lu Z; Li Y; Shen L
    Med Oncol; 2012 Dec; 29(5):3029-34. PubMed ID: 22766748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.
    Lo SS; Khorana AA; Javle M; Simon S; Kiefer G; Rajasenan K; Wang H; Hantel A; Shayne M; Hwang J; Schmotzer A; Ramanathan RK
    Oncology; 2010; 78(2):125-9. PubMed ID: 20389134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.